Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Teva Pharmaceutical Industries Ltd.

Latest From Teva Pharmaceutical Industries Ltd.

Teva Seeks Global Resolution Of Opioid Litigation As Bellwether Trial Is Halted

Teva and three distributors settle with two plaintiffs; PBMs are defendants in next case as Teva also reaches an agreement in principal with four attorneys general for global settlement framework. 

Legal Issues Advertising, Marketing & Sales

Teva Defends Vincristine Discontinuation Decision

Amid emotive US mainstream media coverage of shortages of the children’s cancer treatment vincristine, Teva insists it is not to blame after discontinuing production of the chemotherapy agent.

Cancer Manufacturing

Insurance Giant Sues Again On US Pricing

Mylan, Sandoz and Teva, as well as Apotex, Aurobindo, Dr Reddy’s and Lupin, are among the companies accused of price-fixing in the US in an action brought by US insurance giant Humana.

Legal Issues Generic Drugs

Opioid Trial Preview: The Claims, Defenses, And Last-Minute Maneuvers

Trial opens after settlement proposals by three distributors, Teva and J&J fail to gain support of cities and counties. Distributors want to call former FDA Commissioner Kessler to testify over plaintiffs' objections. Judge rules plaintiffs cannot seek future damages.

Legal Issues Advertising, Marketing & Sales
See All

Company Information